03/25/2026
BCI is moving from breakthrough to bedside, and our CEO Andreas Forsland will join other leaders driving that shift this week at Octane OC Neuro Tech Forum.
Join him for a panel on 𝗕𝗖𝗜: 𝗧𝗵𝗲 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻
Also on panel will be:
Amy Kruse, PhD, General Partner and Chief Investment Officer, Satori Capital
Marcus Gerhardt, Co-Founder and CEO, Blackrock Neurotech
Vivek Pinto, PhD, MBA, Director of Medical Affairs, Precision Neuroscience
Expect a real read on what is scaling, what investors are underwriting, and what it takes to deliver durable patient impact across implantable, minimally invasive, and wearable approaches.
Friday, March 27th, 2026, 2:00 PM-2:30 PM